CVE-2018-17538: Axon Evidence Sync
Critical severity, CVSS 9.8. EPSS: 2.5% chance of exploitation in the next 30 days.
Axon (formerly TASER International) Evidence Sync 3.15.89 is vulnerable to process injection. NOTE: the vendor's position is that this CVE is not associated with information that supports any finding of any type of vulnerability
Affected products
- Axon Evidence Sync: version 3.15.89 only
Published 2018-09-26. Last modified 2026-06-17.